COPD: Heterogeneity and Personalized Treatment
Editat de Sang-Do Leeen Limba Engleză Hardback – 21 dec 2017
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1092.39 lei 39-44 zile | |
Springer Berlin, Heidelberg – 4 sep 2018 | 1092.39 lei 39-44 zile | |
Hardback (1) | 1115.30 lei 39-44 zile | |
Springer Berlin, Heidelberg – 21 dec 2017 | 1115.30 lei 39-44 zile |
Preț: 1115.30 lei
Preț vechi: 1173.99 lei
-5% Nou
Puncte Express: 1673
Preț estimativ în valută:
213.54€ • 222.36$ • 177.18£
213.54€ • 222.36$ • 177.18£
Carte tipărită la comandă
Livrare economică 10-15 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783662471777
ISBN-10: 3662471779
Pagini: 300
Ilustrații: VIII, 359 p. 73 illus., 51 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.91 kg
Ediția:1st ed. 2017
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3662471779
Pagini: 300
Ilustrații: VIII, 359 p. 73 illus., 51 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.91 kg
Ediția:1st ed. 2017
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
Professional/practitionerCuprins
Overview.- Introduction: Summary.- Definition.- Epidemiology.- Risk Factors.- Pathology/Pathogenesis/Pathophysiology.- Assessment.- Introduction: Summary.- Symptoms: SGRQ, CAT, MRC.- Spirometry.- Images.- Biomarkers.- Comorbidity.- Heterogeneity.- Introduction: Summary.- Phenotypes of COPD.- Genetics.- Images.- ACOS.- Exacerbation.- Pulmonary Hypertension.- Management.- Introduction: Summary.- Prevention.- Pharmacologic.- Non-pharmacologic: LVR, Rehab, Nutritional support.- Management of exacerbation.- Management of Comorbidities.- Personalized Treatment: current practice and evidences from researches.- Prospective.- Cohort: KOLD, ANOLD; Big data, Network medicine.
Notă biografică
Sang-Do Lee is Professor in Pulmonary and Critical Care Medicine at University of Ulsan College of Medicine. He is the President of Asan Medical Center, Seoul and Director at Clinical Research Center for Chronic Obstructive Airway Diseases.
Caracteristici
Explains how analysis of the heterogeneity of COPD leads to improved, personalized treatment Presents state of the art knowledge on a range of issues related to COPD heterogeneity Describes an appropriate tailored treatment strategy for each subgroup of patients